Osher Van De Voorde Investment Management Moderna, Inc. Transaction History

Osher Van De Voorde Investment Management

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 09, 2024	SELL	$69.51 - $104.43 $156,745 - $235,489	-2,255 Reduced 47.83%	2,460 $244,000
Q3 2023 Oct 10, 2023	SELL	$96.41 - $126.61 $132,563 - $174,088	-1,375 Reduced 22.58%	4,715 $487,000
Q2 2023 Jul 24, 2023	SELL	$118.5 - $160.53 $5,925 - $8,026	-50 Reduced 0.81%	6,090 $739,000
Q4 2022 Jan 12, 2023	SELL	$118.38 - $210.04 $47,352 - $84,016	-400 Reduced 6.12%	6,140 $0
Q3 2022 Oct 05, 2022	SELL	$118.07 - $194.18 $2,951 - $4,854	-25 Reduced 0.38%	6,540 $773,000
Q1 2022 Apr 14, 2022	BUY	$126.46 - $235.05 $15,807 - $29,381	125 Added 1.94%	6,565 $1.13 Million
Q3 2021 Oct 19, 2021	SELL	$221.9 - $484.47 $399,420 - $872,046	-1,800 Reduced 21.84%	6,440 $2.48 Million
Q2 2021 Jul 20, 2021	BUY	$129.91 - $234.98 $48,716 - $88,117	375 Added 4.77%	8,240 $1.94 Million
Q1 2021 Apr 13, 2021	BUY	$109.18 - $185.98 $858,700 - $1.46 Million	7,865 New	7,865 $1.03 Million

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Osher Van De Voorde Investment Management, based on Form 13F filings with the SEC.

Stay updated on Osher Van De Voorde Investment Management with notifications on news.